Cite
MLA Citation
Felipe Samaniego et al.. “Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma.” Leukemia & lymphoma, vol. 62, no. 1, 2021, pp. 58–67. http://access.bl.uk/ark:/81055/vdc_100118922885.0x000039